Published in Am J Gastroenterol on August 01, 2009
Diagnostic utility of major basic protein, eotaxin-3, and leukotriene enzyme staining in eosinophilic esophagitis. Am J Gastroenterol (2012) 2.70
Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol (2013) 1.75
A Japanese case series of 12 patients with esophageal eosinophilia. J Gastroenterol (2010) 1.66
Advances in clinical management of eosinophilic esophagitis. Gastroenterology (2014) 1.48
Epidemiology of eosinophilic esophagitis. Gastroenterol Clin North Am (2014) 1.46
Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease. Am J Gastroenterol (2010) 1.37
Practice patterns for the evaluation and treatment of eosinophilic oesophagitis. Aliment Pharmacol Ther (2010) 1.05
Eosinophilic esophagitis: interactions with gastroesophageal reflux disease. Gastroenterol Clin North Am (2014) 0.87
Distinguishing GERD from eosinophilic oesophagitis: concepts and controversies. Nat Rev Gastroenterol Hepatol (2015) 0.83
Development of food allergies in patients with gastroesophageal reflux disease treated with gastric acid suppressive medications. Pediatr Allergy Immunol (2013) 0.82
Food allergy: only a pediatric disease? Gerontology (2010) 0.81
Eosinophilic esophagitis and proton pump inhibitors: controversies and implications for clinical practice. Gastroenterol Hepatol (N Y) (2014) 0.80
Curious elements of esophageal foreign body impaction and eosinophilic esophagitis. Gastroenterol Hepatol (N Y) (2009) 0.79
An Overview of the Diagnosis and Management of Eosinophilic Esophagitis. Clin Transl Gastroenterol (2016) 0.78
Re: Might the use of acid-suppressive medications predispose to the development of eosinophilic esophagitis? Am J Gastroenterol (2010) 0.76
PPIs may not predispose to eosinophilic esophagitis. Am J Gastroenterol (2010) 0.76
Eosinophilic Esophagitis: Current Aspects of a Recently Recognized Disease. Gastroenterology Res (2010) 0.75
Environmental and infectious factors in eosinophilic esophagitis. Best Pract Res Clin Gastroenterol (2015) 0.75
Acid-suppressive therapy and eosinophilic esophagitis: friends or foes? Am J Gastroenterol (2010) 0.75
PPIs and food allergy. Am J Gastroenterol (2010) 0.75
Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut (2012) 2.00
Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Dig Dis Sci (2009) 1.91
The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review. Am J Gastroenterol (2012) 1.81
Acid, bile, and CDX: the ABCs of making Barrett's metaplasia. Am J Physiol Gastrointest Liver Physiol (2008) 1.53
Buried metaplasia after endoscopic ablation of Barrett's esophagus: a systematic review. Am J Gastroenterol (2011) 1.50
Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. Gastroenterology (2002) 1.46
Sorafenib for treatment of hepatocellular carcinoma: a systematic review. Dig Dis Sci (2012) 1.45
Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett's esophagus. Dis Esophagus (2008) 1.07
Fatal hyperammonemic encephalopathy after gastric bypass surgery. Am J Med (2008) 1.03
Pneumatic dilation and laparoscopic Heller's myotomy equally effective for achalasia. N Engl J Med (2011) 1.01
A systematic review of the risk of perforation during esophageal dilation for patients with eosinophilic esophagitis. Dig Dis Sci (2010) 0.99
Managing Barrett's oesophagus. BMJ (2003) 0.98
Re-examination of the cost-effectiveness of surgical versus medical therapy in patients with gastroesophageal reflux disease: the value of long-term data collection. Am J Gastroenterol (2004) 0.96
Esophageal adenocarcinoma arising in Barrett esophagus. Cancer Lett (2008) 0.96
Integrated approach to treatment of children and adults with eosinophilic esophagitis. Gastrointest Endosc Clin N Am (2008) 0.93
High-frequency probe ultrasonography has limited accuracy for detecting invasive adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: a case series. Am J Gastroenterol (2006) 0.87
Carcinogenesis at the gastroesophageal junction: free radicals at the frontier. Gastroenterology (2002) 0.86
Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett's cells. Am J Physiol Gastrointest Liver Physiol (2012) 0.85
Stem cells in Barrett's esophagus: HALOs or horns? Gastrointest Endosc (2008) 0.84
Intestinal metaplasia at the gastroesophageal junction: Barrett's, bacteria, and biomarkers. Am J Gastroenterol (2003) 0.82
Banding without resection (endoscopic mucosal ligation) as a novel approach for the ablation of short-segment Barrett's epithelium: results of a pilot study. Am J Gastroenterol (2007) 0.81
Development and characterization of a surgical mouse model of reflux esophagitis and Barrett's esophagus. J Gastrointest Surg (2013) 0.81
Irreversible ototoxicity associated with difluoromethylornithine. Cancer Epidemiol Biomarkers Prev (2004) 0.81
Upper gastrointestinal bleeding in a patient with AIDS. Nat Clin Pract Gastroenterol Hepatol (2006) 0.81
Surgery for gastroesophageal reflux disease: esophageal impedance to progress? Clin Gastroenterol Hepatol (2009) 0.80
Barrett's Esophagus without dysplasia: wait or ablate? Dig Dis Sci (2011) 0.77
Laryngopharyngeal reflux: a cause of faulty phonation or a faulted, phony diagnosis? Clin Gastroenterol Hepatol (2006) 0.77
GERD is associated with shortened telomeres in the squamous epithelium of the distal esophagus. Am J Physiol Gastrointest Liver Physiol (2007) 0.77
Biomarkers and photodynamic therapy for Barrett's esophagus: time to FISH or cut bait? Gastroenterology (2008) 0.77
Barrett's esophagus: is the goblet half empty? Clin Gastroenterol Hepatol (2012) 0.76
Buried (but not dead) Barrett's metaplasia: tales from the crypts. Gastrointest Endosc (2012) 0.75
Esophageal human β-defensin expression in eosinophilic esophagitis. Pediatr Res (2013) 0.75
Cardiac mucosa, Barrett's oesophagus and cancer of the gastro-oesophageal junction: what's in a name? Gut (2016) 0.75